VLU3B021

NCI-H2170-Luc

This NCI-H2170 luciferase stable cell line is made by lentivirus. Luciferase is stably expressed, and the luciferase activity is validated.

Product Images

Key Facts

Product name: NCI-H2170-Luc
Catalog No.: VLU3B021
Form: Ship in dry ice
Note: FOR RESEARCH USE ONLY

Product size: 1*10^6 cells/vial

Product price: Please inquire

Lead time: 4-5 weeks

This NCI-H2170 luciferase stable cell line is made by lentivirus. Luciferase is stably expressed, and the luciferase activity is validated.

Key facts

Product name

NCI-H2170-Luc

Catalog No.

VLU3B021

Shipping and Storage

Ship in dry ice, store in liquid nitrogen vapor phase

Description

NCI-H2170 Luciferase Cell Line engineered for stable, high-efficiency expression of the luciferase gene.This advanced tool delivers exceptionally high imaging quality and precise, quantifiable luminescence, ensuring your data is both robust and publication-ready.
Designed for versatility, the NCI-H2170 Luciferase Cell Line seamlessly adapts to a broad spectrum of applications—from promoter activity assays and mammalian two-hybrid studies to sophisticated in vivo imaging.
The NCI-H2170 cell line was established in 1989 and was derived from a male patient with squamous cell carcinoma of the lung, who was a non-smoker.

Properties

Host cell line

Human lung squamous cell carcinoma cell line (NCI-H2170)

Alias

H2170; H-2170; NCIH2170

Species

Homo sapiens, human

Tissue origin

Lung

Target

Firefly luciferase

Application

Lumi test: Substrate D-Luciferin

Method

Lentivirus tranduction

Form

Poly-clonal

Quality control

Lumi-signal test

STR profiling

Cell culture

Biosafety level

Adherent/suspension

Adherent

Morphology

Epithelial-like

Culture medium

RPMI-1640 Medium +10% FBS

Freezing medium

90% FBS+10% DMSO

Downloads

Datasheet

Safety datasheet

Protocol

For further support, please contact us.

*Publications utilizing this product should include the following acknowledgment: "The NCI-H2170-Luc (Cat. No. VLU3B021) was obtained from Vitro Biotech, Inc."